Fundraising FoxBeiGene
Venture capitalChangping · Series A–Series B · 38 people tracked
Find your way into BeiGene
Sign up to see every warm intro you have to BeiGene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BeiGene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BeiGene (branded as BeOne) is a global biotechnology/pharmaceutical company that develops and commercializes cancer treatments and other medicines, not a venture capital investor.
Source: firm website, verified Aug 16, 2026.
Team · 38 people
from the firm's website
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does BeiGene invest at?
- BeiGene invests at the Series A, Series B stages.
- What sectors does BeiGene focus on?
- BeiGene focuses on Biotech, Healthtech.
- Where is BeiGene located?
- BeiGene is headquartered in Changping, CN.
Media · Podcasts & interviews
featuring the teamBeiGene CEO John V. Oyler's Welcome Remarks on BeiGene Virtual Congress Site
BeiGene · John V. Oyler
Similar investors
Madrona Venture Group is a venture capital firm that backs founding teams at the seed, early, and acceleration stages, with a focus on Seattle, the Bay Area, and beyond.
Wing Venture Capital is an early-stage venture fund backing founders building the AI-first economy across infrastructure, enterprise, physical, domain-specific, security, and healthcare AI.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Quadrille is an independent investment manager focused on venture capital and growth equity, investing globally in technology and healthcare assets.
Avego is a healthcare-focused investment firm that partners with entrepreneurs and management teams across private and public companies developing products and services throughout the healthcare continuum. Its Avego BioScience Capital strategy focuses on mid-to-late stage venture financings for biotech companies.